|
Multiple Sclerosis/ Demyelinating Disease
Contributing journals to this collection:
JAMA & Archives Journals
Citations 331-340 of 370 total displayed.
- Neurological Reviews
The Molecular Pathogenesis of Pelizaeus-Merzbacher Disease
- James Garbern; Franca Cambi; Michael Shy; John Kamholz
Arch Neurol 1999; 56: 1210-1214.
[Extract]
[Full text]
[PDF]
- Original Contributions
Course of Depression During the Initiation of Interferon Beta-1a Treatment for Multiple Sclerosis
- David C. Mohr; William Likosky; Pat Dwyer; Judy Van Der Wende; Arne C. Boudewyn; Donald E. Goodkin
Arch Neurol 1999; 56: 1263-1265.
[Abstract]
[Full text]
[PDF]
- Neurotherapeutics
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
- Richard A. Rudick
Arch Neurol 1999; 56: 1079-1084.
[Extract]
[Full text]
[PDF]
- Original Contributions
Multiple Sclerosis That Is Progressive From the Time of Onset: Clinical Characteristics and Progression of Disability
- P. B. Andersson; E. Waubant; L. Gee; D. E. Goodkin
Arch Neurol 1999; 56: 1138-1142.
[Abstract]
[Full text]
[PDF]
- Basic Science Seminars in Neurology
Proton Magnetic Resonance Spectroscopy for the Diagnosis and Management of Cerebral Disorders
- Teresa M. Rudkin; Douglas L. Arnold
Arch Neurol 1999; 56: 919-926.
[Abstract]
[Full text]
[PDF]
- Observations
Syringomyelia and Complex Regional Pain Syndrome as Complications of Multiple Sclerosis
- Asha Das; K. Puvanendran
Arch Neurol 1999; 56: 1021-1024.
[Abstract]
[Full text]
[PDF]
- Controversies in Neurology
Intravenous Immunoglobulin Treatment in Neurologic Disorders: Yes
- Per Soelberg Sorensen
Arch Neurol 1999; 56: 1025-1027.
[Extract]
[Full text]
[PDF]
- Controversies in Neurology
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?: No
- Dimitrios Karussis; Oded Abramsky
Arch Neurol 1999; 56: 1028-1032.
[Extract]
[Full text]
[PDF]
- Controversies in Neurology
Intravenous Immunoglobulin Treatment in Neurologic Disorders
- Vladimir Hachinski
Arch Neurol 1999; 56: 1032.
[Extract]
[Full text]
[PDF]
- Clinical Crossroads Update
A 29-Year-Old Man With Multiple Sclerosis, 1 Year Later
- Thomas L. Delbanco; Erin E. Hartman
JAMA 1999; 281: 2329.
[Extract]
[Full text]
[PDF]
|
Advertisement


|
|
|